NEODECANOIC ACID
General Information
Mainterm | NEODECANOIC ACID |
CAS Reg.No.(or other ID) | 26896-20-8 |
Regnum |
178.1010 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 62838 |
IUPAC Name | 7,7-dimethyloctanoic acid |
InChI | InChI=1S/C10H20O2/c1-10(2,3)8-6-4-5-7-9(11)12/h4-8H2,1-3H3,(H,11,12) |
InChI Key | YPIFGDQKSSMYHQ-UHFFFAOYSA-N |
Canonical SMILES | CC(C)(C)CCCCCC(=O)O |
Molecular Formula | C10H20O2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 172.268 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Complexity | 133.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D g C A g A A C C A A A A g A I A A C Q C A A A A A A A A A A A A A E A A A A A A B I A A A A A Q A A E A A A A A A G I y O C N A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 37.3 |
Monoisotopic Mass | 172.146 |
Exact Mass | 172.146 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9795 |
Human Intestinal Absorption | HIA+ | 0.9619 |
Caco-2 Permeability | Caco2+ | 0.7562 |
P-glycoprotein Substrate | Non-substrate | 0.5727 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9502 |
Non-inhibitor | 0.7457 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9312 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7016 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7886 |
CYP450 2D6 Substrate | Non-substrate | 0.8963 |
CYP450 3A4 Substrate | Substrate | 0.5060 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6691 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7989 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9609 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9315 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9604 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9745 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9775 |
Non-inhibitor | 0.8866 | |
AMES Toxicity | Non AMES toxic | 0.9431 |
Carcinogens | Non-carcinogens | 0.5955 |
Fish Toxicity | High FHMT | 0.9227 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9996 |
Honey Bee Toxicity | High HBT | 0.7205 |
Biodegradation | Not ready biodegradable | 0.7379 |
Acute Oral Toxicity | III | 0.6985 |
Carcinogenicity (Three-class) | Non-required | 0.7155 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.1854 | LogS |
Caco-2 Permeability | 1.3677 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.5506 | LD50, mol/kg |
Fish Toxicity | 1.9546 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.7049 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty acids and conjugates |
Intermediate Tree Nodes | Not available |
Direct Parent | Medium-chain fatty acids |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Medium-chain fatty acid - Branched fatty acid - Monocarboxylic acid or derivatives - Carboxylic acid - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. |
From ClassyFire